Current Suspected Overdose Deaths in Delaware for 2022: Get Help Now!
In October of 2019, Delaware’s Division of Medicaid and Medical Assistance (DMMA) was one of 15 states nationally to be awarded a planning grant from the Centers for Medicare and Medicaid Services (CMS) under section 1003 of the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act. In October of 2021, DMMA was one of five states to be awarded a SUPPORT Act Demonstration Project, a 36-month initiative beginning September 30, 2021, and running through September 30, 2024. DMMA is using this funding to assess and improve the capacity of Medicaid substance use disorder (SUD) providers to serve Medicaid beneficiaries with SUD.
With funding from the SUPPORT Act Planning Grant, DMMA contracted with the University of Delaware Center for Community Research and Service to produce the Annual Prevalence Report (2014-2019) for Substance Use Disorder Among Medicaid Clients. The report includes statewide SUD and opioid use disorder (OUD) prevalence rates among Delaware Medicaid beneficiaries, as well as other key indicators such as demographics and subpopulations impacted by SUD/OUD, rates of co-occurring mental illness and polysubstance use, and county- and zip code-level OUD prevalence rates. To view the report, click here.
In December 2020, DMMA contracted with Health Management Associates to release a structured survey to Delaware SUD providers to collect information on the costs associated with delivering SUD services. Data from returned surveys, qualitative feedback from providers, and data from other external sources (e.g., Bureau of Labor Statistics’ data) were used to inform draft rate models. Draft rate models were presented to SUD providers on January 26, 2022; find webinar recording here and slides here. On April 20, 2022, additional details were presented about SUD rate model construction and assumptions; find the webinar recording here, the slides here, and the updated draft rate models here. DMMA is soliciting preliminary feedback on these updated draft rates through May 11, 2022. It is also anticipated that a public comment period will be held in June regarding the proposed SUD rates. More details to follow. Please contact Jacob.Bowling@delaware.gov if you have any questions.
DMMA is offering a two-day virtual training on SAMHSA's Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorders and Their Infants, on February 22 and February 23, 2022. This training will provide comprehensive, evidence-based information to provide the optimal management of pregnant and parenting women with opioid use disorder and their infants. The training highlights successful approaches for caring for the mother with opioid use disorder and her child. This training is targeted towards physicians and providers, nurses, social workers, licensed professional counselors, peer support specialists, recovery coaches, and addictions professionals who treat opioid use disorder. For more information or to register, please visit www.delawareppw.org or email Dara.Hall@delaware.gov.